As additional confirmation of the immune modulating role of cancer cells, in the peripheral blood of CRC patients, we found the presence of CD4+ Tnull cells, whose percentage was significantly higher than that in healthy controls. This evidence concerns the gene CD4 and colorectal carcinoma.